Evidence map›Paper›PMID 38966369›Full record

ArticleChemical science2024

Facile synthesis of a hydrazone-based zinc(ii) complex for ferroptosis-augmented sonodynamic therapy.

Dan Li, Minghui Fan, Haobing Wang, Yongjie Zhu, Bole Yu, Pingyu Zhang, Huaiyi Huang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Chemical science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Early Transition Metal-Based Antitumor Complexes.Chemistry, an Asian journal · 2026
    Review
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Dan LiCollege of Chemistry and Environmental Engineering, Shenzhen University Shenzhen 518060 China p.zhang6@szu.edu.cn.
Minghui FanCollege of Chemistry and Environmental Engineering, Shenzhen University Shenzhen 518060 China p.zhang6@szu.edu.cn.
Haobing WangCollege of Chemistry and Environmental Engineering, Shenzhen University Shenzhen 518060 China p.zhang6@szu.edu.cn.
Yongjie ZhuCollege of Chemistry and Environmental Engineering, Shenzhen University Shenzhen 518060 China p.zhang6@szu.edu.cn.
Bole YuLaboratory of Life Science, Shenzhen Research Institute of the Hong Kong Polytechnic University Shenzhen 518057 China.
Pingyu ZhangCollege of Chemistry and Environmental Engineering, Shenzhen University Shenzhen 518060 China p.zhang6@szu.edu.cn.ORCID https://orcid.org/0000-0002-2921-9490
Huaiyi HuangSchool of Pharmaceutical Science (Shenzhen), Shenzhen Campus of Sun Yat-sen University No. 66, Gongchang Road Shenzhen 518107 China.ORCID https://orcid.org/0000-0002-2091-7954

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sonodynamic therapy (SDT), as a novel non-invasive cancer treatment modality derived from photodynamic therapy (PDT), has drawn much attention due to its unique advantages for the treatment of deep tumors. Zinc-based complexes have shown great clinical prospect in PDT due to their excellent photodynamic activity and biosafety. However, their application in SDT has lagged seriously behind. Exploring efficient zinc-based complexes as sono-sensitizers remains an appealing but significantly challenging task. Herein, we develop a hydrazone ligand-based zinc complex (ZnAMTC) for SDT of tumors

Identifiers

PMID38966369
PMCPMC11220576

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.